Assessing the prevalence, gender differences and factors associated with human papillomavirus vaccination among medical students of a tertiary care hospital: a cross-sectional study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20254049Keywords:
Human papillomavirus, Cervical cancer, VaccinationAbstract
Background: Human papillomavirus (HPV) vaccination protects individuals from HPV-related cancers, especially cervical cancer. Globally, we see underutilization of HPV vaccination, and the situation remains unfavorable in India, where cultural constraints along with insufficient education about HPV create significant challenges to vaccination adoption.
Methods: This cross-sectional study enrolled 350 medical students from a tertiary care hospital in Karnataka. The study assessed student’s knowledge levels, vaccination state, and attitudes. Statistical calculations through statistical package for the social sciences (SPSS) v26 produced results that analyzed descriptive and inferential statistics and evaluated the relationships between variables.
Results: HPV vaccination rates among students were relatively low, with only 10% of students receiving HPV vaccination. The understanding of HPV and its vaccine showed greater levels among female students (56.8%) over male students (43.2%). Factors influencing vaccine uptake included when students had better knowledge about HPV transmission and positive views on vaccine effectiveness and cervical cancer prevention benefits. Students faced primary obstacles to vaccine adoption because they were not aware of vaccine information, had incorrect perceptions about vaccine recommendations, and were worried about social discrimination. Most of the students (72%) showed positive attitudes that vaccine benefits health in the future. Females displayed superior awareness about HPV risks, vaccine-related advantages, compared to males.
Conclusion: A total of 66% of students showed an intention to get the HPV vaccine. Medical students generally understand HPV-related diseases and prevention practices. Several knowledge gaps demand additional educational content about HPV diseases and vaccine advantages to be included in the medical learning programs.
Metrics
References
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2020. Available at: https://www.who.int/publications/i/item/9789240014107. Accessed on 10 September 2025.
Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, et al. Human Papillomavirus and Related Diseases Report. ICO/IARC HPV Information Centre. Am J Med Sci Med. 2020;8(1):21-33.
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;5. DOI: https://doi.org/10.1002/ijc.33588
Pandey D, Vanya V, Bhagat S, Binu VS, Shetty J. Awareness and attitude towards human papillomavirus vaccine among medical students in a premier medical school in India. PLoS One. 2012;7(7):e40619. DOI: https://doi.org/10.1371/journal.pone.0040619
Mehta S, Rajaram S, Goel G, Goel N. Awareness about Human Papilloma Virus and its Vaccine Among Medical Students. Indian J Community Med. 2013;38(2):92-4. DOI: https://doi.org/10.4103/0970-0218.112438
Drolet M, Bénard É, Pérez N, Brisson M; HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497-509. DOI: https://doi.org/10.1016/S0140-6736(19)30298-3
Ministry of Health and Family Welfare, Government of India. Pilot introduction of HPV vaccine in India: Lessons learned. New Delhi: MoHFW. 2022.
National Technical Advisory Group on Immunization (NTAGI). Recommendations for HPV vaccine inclusion in the Universal Immunization Programme. New Delhi: MoHFW. 2022.
Basu P, Malvi SG, Joshi S, Bhatla N, Muwonge R, Lucas E, et al. Vaccine efficacy against persistent human papillomavirus 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. Lancet Oncol. 2021;22(11):1518-29. DOI: https://doi.org/10.1016/S1470-2045(21)00453-8
Swarnapriya K, Kavitha D, Reddy GM. Knowledge, Attitude and Practices Regarding HPV Vaccination Among Medical and Para Medical in Students, India a Cross Sectional Study. Asian Pac J Cancer Prev. 2015;16(18):8473-7. DOI: https://doi.org/10.7314/APJCP.2015.16.18.8473
World Health Organization. Cervical cancer elimination initiative: Progress and goals. 2021. Available at: https://www.who.int/initiatives/ cervical-cancer-elimination-initiative. Accessed on 10 September 2025.
Kangmennaang J, Malik J, Peace J, Meyer SB, Elliott SJ. HPV vaccine acceptance among young adults in low-income countries: A scoping review. BMC Public Health. 2020;20(1):1565.
Coursey K, Muralidhar K, Srinivas V, Jaykrishna P, Begum F, Ningaiah N, et al. Acceptability of HPV vaccination for cervical cancer prevention among emerging adult women in rural Mysore, India: a mixed-methods study. BMC Public Health. 2024;24:2139. DOI: https://doi.org/10.1186/s12889-024-19485-8
Dempsey AF, Davis MM. Overcoming barriers to adherence to HPV vaccination recommendations. Am J Manag Care. 2006;12:S484-91.
Gavi, the Vaccine Alliance. HPV vaccines: Boosting uptake in developing countries. Geneva: Gavi. 2022. Available at: https://www.gavi.org/types-support/ vaccine-support/human-papillomavirus. Accessed on 10 September 2025.
Shetty S, Prabhu S, Shetty V, Shetty AK. Knowledge, attitudes and factors associated with acceptability of human papillomavirus vaccination among undergraduate medical, dental and nursing students in South India. Hum Vaccin Immunother. 2019;15(7-8):1656-65. DOI: https://doi.org/10.1080/21645515.2019.1565260
Downloads
Published
How to Cite
Issue
Section
